The results proved that FOXQ1 expression was positively correlated with the stromal and immune score in breast invasive carcinoma, prostate adenocarcinoma, thyroid carcinoma, lung adenocarcinoma, and ovarian serous cystadenocarcinoma. The gene discussed is FOXQ1; the disease is thyroid gland carcinoma.